Man Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.6M | Buy |
394,449
+36,607
| +10% | +$2.44M | 0.04% | 410 |
|
|
2026
Q1 | $22.5M | Sell |
357,842
-604,750
| -63% | -$42.1M | 0.04% | 447 |
|
|
2025
Q4 | $63.9M | Buy |
962,592
+378,902
| +65% | +$24.5M | 0.11% | 196 |
|
|
2025
Q3 | $39.3M | Buy |
583,690
+125,860
| +27% | +$9.96M | 0.07% | 308 |
|
|
2025
Q2 | $40M | Buy |
457,830
+163,700
| +56% | +$12.8M | 0.08% | 291 |
|
|
2025
Q1 | $20.1M | Sell |
294,130
-10,285
| -3% | -$839K | 0.05% | 445 |
|
|
2024
Q4 | $23.7M | Sell |
304,415
-707,932
| -70% | -$52.4M | 0.06% | 366 |
|
|
2024
Q3 | $67.9M | Sell |
1,012,347
-241,746
| -19% | -$19.9M | 0.18% | 141 |
|
|
2024
Q2 | $142M | Buy |
1,254,093
+991,319
| +377% | +$125M | 0.36% | 46 |
|
|
2024
Q1 | $36.4M | Buy |
262,774
+30,508
| +13% | +$3.83M | 0.09% | 253 |
|
|
2023
Q4 | $28.8M | Buy |
+232,266
| New | +$23.7M | 0.08% | 287 |
|
|
2023
Q3 | – | Sell |
-519,489
| Closed | -$58.6M | – | 137 |
|
|
2023
Q2 | $66.8M | Buy |
+519,489
| New | +$62.8M | 0.21% | 105 |
|
|
2023
Q1 | – | Sell |
-546,576
| Closed | -$61.2M | – | 255 |
|
|
2022
Q4 | $61.9M | Buy |
546,576
+227,338
| +71% | +$25M | 0.22% | 95 |
|
|
2022
Q3 | $25.7M | Buy |
+319,238
| New | +$27M | 0.12% | 217 |
|
|
2022
Q2 | – | Sell |
-61,480
| Closed | -$5.61M | – | 312 |
|
|
2022
Q1 | $7.86M | Sell |
61,480
-212,760
| -78% | -$23.3M | 0.03% | 705 |
|
|
2021
Q4 | $36.8M | Sell |
274,240
-30,552
| -10% | -$4.39M | 0.12% | 191 |
|
|
2021
Q3 | $41.7M | Buy |
304,792
+119,072
| +64% | +$15M | 0.15% | 151 |
|
|
2021
Q2 | $19.8M | Buy |
185,720
+122,640
| +194% | +$11.8M | 0.07% | 321 |
|
|
2021
Q1 | $5.67M | Sell |
63,080
-43,328
| -41% | -$4.07M | 0.02% | 631 |
|
|
2020
Q4 | $9.84M | Buy |
106,408
+29,100
| +38% | +$2.6M | 0.04% | 456 |
|
|
2020
Q3 | $7.97M | Buy |
77,308
+29,164
| +61% | +$3.05M | 0.03% | 576 |
|
|
2020
Q2 | $4.88M | Buy |
48,144
+9,664
| +25% | +$864K | 0.02% | 672 |
|
|
2020
Q1 | $2.59M | Buy |
38,480
+32,220
| +515% | +$2M | 0.02% | 779 |
|
|
2019
Q4 | $342K | Sell |
6,260
-160
| -2% | -$7.59K | ﹤0.01% | 1648 |
|
|
2019
Q3 | $239K | Sell |
6,420
-139,772
| -96% | -$5.43M | ﹤0.01% | 1683 |
|
|
2019
Q2 | $5.48M | Sell |
146,192
-97,772
| -40% | -$3.07M | 0.02% | 912 |
|
|
2019
Q1 | $7.26M | Sell |
243,964
-175,056
| -42% | -$6.15M | 0.03% | 729 |
|
|
2018
Q4 | $12.5M | Buy |
419,020
+45,384
| +12% | +$1.44M | 0.06% | 381 |
|
|
2018
Q3 | $13.4M | Buy |
373,636
+105,076
| +39% | +$3.26M | 0.05% | 484 |
|
|
2018
Q2 | $6.38M | Buy |
+268,560
| New | +$5.69M | 0.03% | 816 |
|
Other funds holding DXCM
Man Group's DXCM Position: Q2 2026 in Review
Man Group increased its DexCom (DXCM) stake by 10% in Q2 2026, buying an estimated $2.44M and bringing the position to 394,449 shares worth $26.6M. The position accounts for 0.04% of the portfolio, ranked #410.
Man Group first reported a position in DXCM in Q2 2018 and has held it in 30 quarters since. The position peaked at $142M in Q2 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Man Group held 394,449 shares of DexCom worth $26.6M as of Q2 2026.
- Man Group bought 36,607 DexCom shares in Q2 2026, an estimated $2.44M.
- DexCom made up 0.04% of Man Group's portfolio in Q2 2026, its #410 holding.
- Man Group first reported a position in DexCom in Q2 2018 and has held it in 30 quarters since.
- Man Group's DexCom position peaked at $142M in Q2 2024.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.